These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 494138)

  • 1. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cavinton prevention of neurosensory hypoacousis in patients with different forms of tuberculosis].
    Maliavina US; Ovchinnikov IuM; Fasenko VP; Maliev BM; Kalinina MV; Dadasheva BB
    Vestn Otorinolaringol; 2003; (3):35-40. PubMed ID: 12847806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary report on the use of ethyl apovincaminate in affections of the eyeground.
    Brooser G; Anda L; Domán J
    Arzneimittelforschung; 1976; 26(10a):1973-5. PubMed ID: 1037226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant effect of cavinton in the treatment of climacteric symptoms.
    Kiss E
    Ther Hung; 1990; 38(4):170-3. PubMed ID: 2094056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prospects of using cavinton for treating Ménière's disease].
    Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
    Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
    [No Abstract]   [Full Text] [Related]  

  • 9. [Usefulness of vasodilator agents Cavinton and Halidor in circulatory insufficiency of the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Bednarczyk-Kałuzna M
    Przegl Lek; 1982; 39(9):617-20. PubMed ID: 7178532
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with the use of cavinton in the treatment of patients with incipient senile atherosclerotic encephalopathy].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN; Litvinenko AA; Bachinskaia NIu
    Vrach Delo; 1987 Jan; (1):46-9. PubMed ID: 3564418
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of cavinton in neuropaediatrics].
    Studenikin VM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(12):63-4. PubMed ID: 15847328
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.
    Jasper A
    Ther Hung; 1979; 27(1):29-31. PubMed ID: 386551
    [No Abstract]   [Full Text] [Related]  

  • 13. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 14. Cavinton, a new cerebral vasodilator.
    Solti F
    Ther Hung; 1979; 27(1):15-6. PubMed ID: 494137
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trental and Cavinton in the treatment of cochleovestibular disorders].
    Hahn A; Holcát M
    Cesk Otolaryngol; 1984 Jul; 33(4):264-7. PubMed ID: 6333291
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Delayed-action pervincamine forte in circulatory disorders of the posterior segment of the eye].
    Bregeat P; Ryzman P
    Rev Otoneuroophtalmol; 1975; 47(5):353-8. PubMed ID: 1215739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ocular manifestations of hepatitis B].
    Cuşnir V; Slepova O; Dumbravă V; Zaiţeva N; Cuşnir R; Midrigan I
    Oftalmologia; 1997; 41(2):25-7. PubMed ID: 15328636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cavinton and sulfocamphocain on systemic and cerebral hemodynamics in patients with early forms of cerebrovascular diseases].
    Ishchenko MM; Shkrobot SI; Borak VT
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(8):1160-4. PubMed ID: 3673409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of kavinton on bronchial tonus in bronchial asthma patients].
    Karashurov SE
    Eksp Klin Farmakol; 1994; 57(6):35-6. PubMed ID: 7756957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.